Boxer Capital’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,123,105
Closed -$25.9M 91
2020
Q4
$25.9M Hold
1,123,105
0.83% 33
2020
Q3
$11.4M Hold
1,123,105
0.4% 50
2020
Q2
$16.7M Hold
1,123,105
0.74% 37
2020
Q1
$13.7M Hold
1,123,105
0.93% 30
2019
Q4
$17.8M Hold
1,123,105
1.01% 28
2019
Q3
$13.8M Hold
1,123,105
1% 25
2019
Q2
$14.8M Buy
+1,123,105
New +$14.8M 1.27% 21